Clinical trial
A Double Blind Placebo-controlled Randomized Study of Varicella Zoster Vaccine in Patients With Moderate-to-severe Plaque Psoriasis Who Are Candidates for Biologic Therapy
NCT02408159 is registered in ClinicalTrials.gov with Innovaderm Research Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Double Blind Placebo-controlled Randomized Study of Varicella Zoster Vaccine in Patients With Moderate-to-severe Plaque Psoriasis Who Are Candidates for Biologic Therapy
- Lead sponsor
- Innovaderm Research Inc.
- Phase
- Phase 4
- Overall status
- Terminated
- Start date
- June 30, 2016
- Completion date
- March 31, 2017
- Enrollment
- 3 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.